Drug Point: Strontium ranelate may cause alopecia

BMJ (Online)

Volumn 338, Issue 7704, 2009, Pages 1210-

  Sainz, María ^a   Del Pozo, Javier García ^a   Martín Arias, Luis H ^a   Carvajal, Alfonso ^a,b  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; STRONTIUM RANELATE; BONE DENSITY CONSERVATION AGENT; ORGANOMETALLIC COMPOUND; THIOPHENE DERIVATIVE;

ALOPECIA; BODY IMAGE; CORRELATION ANALYSIS; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; FEMALE; HIGH RISK POPULATION; HUMAN; JAW OSTEONECROSIS; MAJOR CLINICAL STUDY; OSTEOPOROSIS; PAIN; POSTMENOPAUSE; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; SELF ESTEEM; SHORT SURVEY; SPAIN; AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; MIDDLE AGED; POSTMENOPAUSE OSTEOPOROSIS;

AGED; ALOPECIA; BONE DENSITY CONSERVATION AGENTS; HUMANS; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; OSTEOPOROSIS, POSTMENOPAUSAL; THIOPHENES;

EID: 67650077534     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b1494     Document Type: Short Survey

References (4)

1. Powis SJA, Waterworth TA, Arkell DG. Preoperative skin preparation: clinical evaluation of depilatory cream. BMJ 1976;2:1166-8.[Abstract/Free Full Text]
2. Woo SB, Hellstein JW, Kalmar JR. Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 2006;16:753-61.
3. Lenzer J. US drugs regulator issues severe pain alert on bisphosphonates. BMJ 2008;336:117.[Free Full Text]
4. Hunt N, McHale S. The psychological impact of alopecia. BMJ 2005;331:951-3.[Free Full Text]